BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Büttner P, Okun JG, Hauke J, Holzwirth E, Obradovic D, Hindricks G, Thiele H, Kornej J. Trimethylamine N-oxide in atrial fibrillation progression. Int J Cardiol Heart Vasc 2020;29:100554. [PMID: 32885030 DOI: 10.1016/j.ijcha.2020.100554] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Huang K, Wang Y, Bai Y, Luo Q, Lin X, Yang Q, Wang S, Xin H. Gut Microbiota and Metabolites in Atrial Fibrillation Patients and Their Changes after Catheter Ablation. Microbiol Spectr 2022;:e0107721. [PMID: 35384710 DOI: 10.1128/spectrum.01077-21] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
2 Huang R, Yan L, Lei Y. The Gut Microbial-Derived Metabolite Trimethylamine N-Oxide and Atrial Fibrillation: Relationships, Mechanisms, and Therapeutic Strategies. Clin Interv Aging 2021;16:1975-86. [PMID: 34876810 DOI: 10.2147/CIA.S339590] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Sikora M, Kiss N, Stec A, Giebultowicz J, Samborowska E, Jazwiec R, Dadlez M, Olszewska M, Rudnicka L. Trimethylamine N-Oxide, a Gut Microbiota-Derived Metabolite, Is Associated with Cardiovascular Risk in Psoriasis: A Cross-Sectional Pilot Study. Dermatol Ther (Heidelb) 2021;11:1277-89. [PMID: 33983475 DOI: 10.1007/s13555-021-00547-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
4 Linz D, Dobrev D. Sleep apnea and atrial fibrillation: Update 2020. Int J Cardiol Heart Vasc 2020;31:100681. [PMID: 33304991 DOI: 10.1016/j.ijcha.2020.100681] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]